C. Hull

NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia

B. Platt, A. Robertson, M. Delibegović, 2020, Neuropharmacology.

Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice.

B. Platt, Shakil Ahmed Khan, V. Gault, 2019, Biochemical pharmacology.

Apolipoprotein E loss of function: Influence on murine brain markers of physiology and pathology

B. Platt, M. Delibegović, C. Hull, 2022, Aging brain.

Neurochemical, histological, and behavioral profiling of the acute, sub‐acute, and chronic MPTP mouse model of Parkinsonʼs disease

B. Platt, G. Riedel, M. Santoro, 2022, Journal of neurochemistry.

Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris.

J. Sundberg, D. Boggess, R. Presland, 2000, The Journal of investigative dermatology.

Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer’s disease

B. Platt, D. Koss, C. Hull, 2018, Brain Research.

The BACE1 inhibitor LY2886721 improves diabetic phenotypes of BACE1 knock-in mice.

B. Platt, G. Riedel, M. Delibegović, 2021, Biochimica et biophysica acta. Molecular basis of disease.

Knock-in of Mutated hTAU Causes Insulin Resistance, Inflammation and Proteostasis Disturbance in a Mouse Model of Frontotemporal Dementia

B. Platt, D. Koss, M. Delibegović, 2019, Molecular Neurobiology.